The molecular basis of retinoids' use in breast cancer chemoprevention

被引：0

作者：

Karamouzis, Michalis V.

Konstantinopoulos, Panagiotis A.

Papavassiliou, Athanasios G. ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece

[2] Univ Pittsburgh, Div Hematol Oncol, Pittsburgh, PA USA

[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA

来源：

CELLULAR ONCOLOGY | 2007年 / 29卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：183 / 184

页数：2

共 8 条

[1]

Husdal A, 2006, CELL ONCOL, V28, P107

[2]

Janssen EAM, 2006, CELL ONCOL, V28, P295

[3] Retinoid receptor cross-talk in respiratory epithelium cancer chemoprevention [J].

Karamouzis, MV ;

Papavassiliou, AG .

TRENDS IN MOLECULAR MEDICINE, 2005, 11 (01) :10-16

[4]

Kortenhorst MSQ, 2006, CELL ONCOL, V28, P191

[5] Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact? [J].

Pritchard, K. I. .

ANNALS OF ONCOLOGY, 2006, 17 (07) :1035-1036

[6] Cyclooxygenase-2 is essential for HER2/neu to suppress N-(4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells [J].

Simeone, AM ;

Li, YJ ;

Broemeling, LD ;

Johnson, MM ;

Tuna, M ;

Tari, AM .

CANCER RESEARCH, 2004, 64 (04) :1224-1228

[7] Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer [J].

Veronesi, U. ;

Mariani, L. ;

Decensi, A. ;

Formelli, F. ;

Camerini, T. ;

Miceli, R. ;

Di Mauro, M. G. ;

Costa, A. ;

Marubini, E. ;

Sporn, M. B. ;

De Palo, G. .

ANNALS OF ONCOLOGY, 2006, 17 (07) :1065-1071

[8] Mechanism of fenretinide (4-HPR)-induced cell death [J].

Wu, JM ;

DiPietrantonio, AM ;

Hsieh, TC .

APOPTOSIS, 2001, 6 (05) :377-388

← 1 →